Stay updated on Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision history updated to include v3.3.3; the HHS Vulnerability Disclosure link and revision v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:04:36.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry v3.3.2, replacing the previous v3.2.0 entry.
    Difference
    0.1%
    Check dated 2025-11-25T10:41:12.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A government funding notice appears, warning that information may not be up to date and that transactions may not be processed, with links to cc.nih.gov and opm.gov for status updates.
    Difference
    0.8%
    Check dated 2025-11-18T06:54:07.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The history shows multiple versions with updates to study status and recruitment across several dates, including a later entry in 2025. This indicates ongoing updates to the trial record.
    Difference
    0.1%
    Check dated 2025-11-03T20:55:46.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    13%
    Check dated 2025-10-06T05:21:23.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T03:01:58.000Z thumbnail image

Stay in the know with updates to Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.